Sumeet Singh

Sumeet Singh is a Scientist at Neurocrine Biosciences since March 2023, focusing on the development of peptide-based antibody drug conjugates. Concurrently, Sumeet serves as a Reviewer for MDPI and previously for the Royal Society of Chemistry. From April 2019 to March 2023, Sumeet held the position of Senior Research Associate (Postdoc) at the University of Washington, specializing in the semisynthesis of the transcription factor p53, which has significant implications for cancer research. Sumeet completed a PhD in Chemistry at the Technion - Israel Institute of Technology from 2014 to 2018 and earned an MS in Chemistry from the Indian Institute of Science Education & Research (IISER), Pune, between 2008 and 2013.